Psoriatic arthropathy and Neutrophil percentage increased
Neutrophil percentage increased is reported only by a few people with Psoriatic arthropathy.
The study analyzes which people have Neutrophil percentage increased with Psoriatic arthropathy. It is created by eHealthMe based on 3 people who have Neutrophil percentage increased and Psoriatic arthropathy from the Food and Drug Administration (FDA), and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
3 people who have Psoriatic Arthropathy and Neutrophil Percentage Increased are studied.
What is Psoriatic arthropathy?
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop) is found to be associated with 906 drugs and 486 conditions by eHealthMe.
What is Neutrophil percentage increased?
Neutrophil percentage increased is found to be associated with 739 drugs and 472 conditions by eHealthMe.
Number of Neutrophil percentage increased in Psoriatic arthropathy reports submitted per year:
Gender of people who have Psoriatic Arthropathy and experienced Neutrophil Percentage Increased *:
- female: 33.33 %
- male: 66.67 %
Age of people who have Psoriatic Arthropathy and experienced Neutrophil Percentage Increased *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 50 %
- 50-59: 50 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Psoriasis (immune-mediated disease that affects the skin): 1 person, 33.33%
Common drugs taken by these people *:
- Neoral: 1 person, 33.33%
- Methylprednisolone: 1 person, 33.33%
- Methotrexate: 1 person, 33.33%
- Folic Acid: 1 person, 33.33%
- Enbrel: 1 person, 33.33%
Common symptoms for these people *:
- Fever: 2 people, 66.67%
- Serum Ferritin Increased: 1 person, 33.33%
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 1 person, 33.33%
- Blood Fibrinogen Decreased: 1 person, 33.33%
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 33.33%
- C-Reactive Protein Increased: 1 person, 33.33%
- Chills (felling of cold): 1 person, 33.33%
- Diffuse Alveolar Damage (common manifestation of drug-induced lung injury): 1 person, 33.33%
- Drug Ineffective: 1 person, 33.33%
- General Physical Health Deterioration (weak health status): 1 person, 33.33%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Neutrophil percentage increased?Check whether Neutrophil percentage increased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Neutrophil percentage increased:
- Neutrophil percentage increased in Moderna COVID Vaccine
- Neutrophil percentage increased in Pfizer BioNTech Covid Vaccine
- Neutrophil percentage increased in Johnson and Johnson Covid Vaccine
Common drugs associated with Neutrophil percentage increased:
All the drugs that are associated with Neutrophil percentage increased:
- Neutrophil percentage increased (739 drugs)
Common conditions associated with Neutrophil percentage increased:
All the conditions that are associated with Neutrophil percentage increased:
- Neutrophil percentage increased (472 conditions)
How the study uses the data?
The study is based on Neutrophil percentage increased and Psoriatic arthropathy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.